Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Standard Medical Therapy

Research Leaders

6 sponsors active, led by Mucosa Innovations, S.L.

Related Conditions

Often studied with 11 related conditions

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 5/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 4 (1)

Trial Status

Completed1
Not Yet Recruiting1
Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT07737782Not Yet Recruiting

Retrospective Cohort Study of Symptoms and Quality of Life in Women With Genitourinary Syndrome of Menopause.

NCT06962345Not ApplicableRecruiting

Changes in the Impact of Genitourinary Syndrome of Menopause With a Novel Nonhormonal Vulvovaginal Gel Assessed by PROMs.

NCT00547378Phase 4CompletedPrimary

InSite for Over Active Bladder

Showing all 3 trials

Research Network

Common Treatments

  • Standard Medical Therapy1
  • Interstim1
  • Hormonefree Vulvovaginal Gel With The Tested Composition Xcmim20m1

Active Sponsors

  • Mucosa Innovations, S.L.2
  • MedtronicNeuro1
  • Hospital de La Luz1
  • Clínica Vilaboa1
  • Hospital Universitario Fundación Jiménez Díaz1

Top Investigators

Related Conditions

  • Womens Health2
  • Menopause Related Conditions2
  • Vulvar Atrophy2
  • Sexual Function2
  • Vulvovaginal Signs And Symptoms2

Activity Timeline